In the U.S. it is estimated that 6.4 million adults have suffered a stroke and another 13 million may have experienced a “silent stroke”, loss of brain cells without visible symptoms. The financial burdens associated with stroke treatment and recovery (both direct and indirect) is estimated to be $73 billion dollars for 2010. In spite of modest declining rates of strokes for the last 7 years, the prevalence of this disease continues to constitute a major source of long-term disabilities for the American public, as well as an expanding cost in health care and household budgets. Drug treatments for brain strokes are only available for patients diagnosed 1-3 hours after the onset of a clot induced stroke. With more than 90% of stroke patients falling outside of this treatment group, new treatments must be developed. Therapies that focus on salvaging and protection of brain tissue in this large group of stroke sufferers is a major focus for the medical and scientific community. One treatment that has the proven ability to salvage oxygen starved tissue is hyperbaric oxygen therapy (HBOT).
read more about the article HERE